CL2019002259A1 - Composición antiséptica que comprende polivinilpirrolidona y unitiol y uso de la composición. - Google Patents
Composición antiséptica que comprende polivinilpirrolidona y unitiol y uso de la composición.Info
- Publication number
- CL2019002259A1 CL2019002259A1 CL2019002259A CL2019002259A CL2019002259A1 CL 2019002259 A1 CL2019002259 A1 CL 2019002259A1 CL 2019002259 A CL2019002259 A CL 2019002259A CL 2019002259 A CL2019002259 A CL 2019002259A CL 2019002259 A1 CL2019002259 A1 CL 2019002259A1
- Authority
- CL
- Chile
- Prior art keywords
- composition
- antiseptic
- unitiol
- wounds
- compositions according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
- A61K31/79—Polymers of vinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
Abstract
LA INVENCIÓN SE REFIERE A NUEVAS COMPOSICIONES ANTISÉPTICAS BASADAS EN POLÍMEROS PARA EL TRATAMIENTO DE HERIDAS Y/O PARA USO EN OPERACIONES QUIRÚRGICAS, QUE FORMAN UNA PELÍCULA EN LA SUPERFICIE DE LA HERIDA Y TIENEN EFECTOS ANTISÉPTICOS, ANESTÉSICOS Y ANTITÓXICOS. LAS COMPOSICIONES DE ACUERDO CON LA INVENCIÓN COMPRENDEN POLIVINILPIRROLIDONA CON UN PESO MOLECULAR PROMEDIO EN PESO EN EL INTERVALO DE 1.000.000 A 3.000.000 DA, UNO O MÁS ANTISÉPTICOS, UNITIOL, DIMETILSULFÓXIDO Y UNO O MÁS ANESTÉSICOS, PREFERENTEMENTE ANESTÉSICOS LOCALES. ADEMÁS, LA PRESENTE INVENCIÓN SE REFIERE AL USO DE LAS COMPOSICIONES DE ACUERDO CON LA INVENCIÓN EN UN TRATAMIENTO DE HERIDAS, ASÍ COMO LOS MÉTODOS PARA TRATAR HERIDAS USANDO LAS COMPOSICIONES DE ACUERDO CON LA INVENCIÓN QUE COMPRENDEN LA ETAPA DE APLICAR LA COMPOSICIÓN DE ACUERDO CON LA INVENCIÓN A UNA SUPERFICIE DE HERIDA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2017106061A RU2649785C1 (ru) | 2017-02-22 | 2017-02-22 | Антисептическая композиция, содержащая поливинилпирролидон и унитиол, применение такой композиции и способ обработки ран с ее использованием |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2019002259A1 true CL2019002259A1 (es) | 2020-01-03 |
Family
ID=61094570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2019002259A CL2019002259A1 (es) | 2017-02-22 | 2019-08-09 | Composición antiséptica que comprende polivinilpirrolidona y unitiol y uso de la composición. |
Country Status (19)
Country | Link |
---|---|
US (1) | US11045551B2 (es) |
EP (1) | EP3585399B1 (es) |
JP (1) | JP6690816B2 (es) |
KR (1) | KR102096257B1 (es) |
CN (1) | CN110198721B (es) |
AU (1) | AU2017400650B2 (es) |
BR (1) | BR112019016560A2 (es) |
CA (1) | CA3054002C (es) |
CL (1) | CL2019002259A1 (es) |
EA (1) | EA037319B1 (es) |
GE (1) | GEP20207136B (es) |
MA (1) | MA46159B1 (es) |
MX (1) | MX2019009761A (es) |
PL (1) | PL3585399T3 (es) |
RU (1) | RU2649785C1 (es) |
SG (1) | SG11201903097UA (es) |
UA (1) | UA121949C2 (es) |
WO (1) | WO2018156051A1 (es) |
ZA (1) | ZA201905343B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2713884C1 (ru) * | 2018-12-18 | 2020-02-10 | Екатерина Николаевна Мехоношина | Жидкая композиция для получения спрея для формирования антимикробной раневой повязки при микротравмах кожи |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2739922A (en) | 1952-03-13 | 1956-03-27 | Herman A Shelanski | Mixtures of polymeric n-vinyl pyrrolidone and halogens |
US3761590A (en) | 1970-05-18 | 1973-09-25 | Research Corp | Silver sulfadiazine used in the treatment of burns |
GB2148901A (en) | 1983-10-04 | 1985-06-05 | Johnson & Johnson | Protein/polysaccharide complexes |
RU2062113C1 (ru) * | 1993-10-19 | 1996-06-20 | Владимир Валентинович Рыльцев | Способ получения перевязочных материалов |
RU2088234C1 (ru) | 1994-11-25 | 1997-08-27 | Институт высокомолекулярных соединений РАН | Водорастворимая бактерицидная композиция и способ ее получения |
UA13954C2 (uk) * | 1996-06-13 | 2001-05-15 | Державний Науковий Центр Лікарських Засобів | Аhтибактеріальhий засіб для місцевого застосуваhhя |
RU2185155C2 (ru) | 2000-04-27 | 2002-07-20 | Кривошеин Юрий Семенович | Клей антисептический ранозаживляющий |
US6828308B2 (en) * | 2000-07-28 | 2004-12-07 | Sinclair Pharmaceuticals, Ltd. | Compositions and methods for the treatment or prevention of inflammation |
RU2175549C1 (ru) * | 2000-10-26 | 2001-11-10 | Закрытое акционерное общество "ТОП-ВЕТ" | Ранозаживляющий лекарственный препарат "зоодерм" |
US10117812B2 (en) * | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
RU2284824C1 (ru) * | 2005-03-18 | 2006-10-10 | Общество с ограниченной ответственностью "Сирена" | Клей хирургический антисептический "аргакол" |
WO2006121219A1 (ja) * | 2005-05-13 | 2006-11-16 | Osaka University | 上皮−間葉転換制御剤 |
BRPI0716270A2 (pt) * | 2006-08-28 | 2013-08-13 | Rexaderm Inc | bandagem de ferida seca e sistema de distribuiÇço de fÁrmaco |
RU2403921C1 (ru) * | 2009-04-01 | 2010-11-20 | Государственное образовательное учреждение высшего профессионального образования "Дальневосточный государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" | Способ комбинированного лечения ограниченной склеродермии с применением локального трансдермального ферментативного электростатического воздействия |
RU2404781C1 (ru) * | 2009-07-23 | 2010-11-27 | Институт элементоорганических соединений РАН (ИНЭОС РАН) | Композиция в качестве бактерицидного средства, способ получения материала на ее основе и макропористый бактерицидный материал на основе данной композиции |
CN103505470A (zh) * | 2012-06-22 | 2014-01-15 | 江苏胜意药业有限公司 | 一种聚维酮碘溶液的生产方法 |
EP3698793A1 (en) * | 2014-01-29 | 2020-08-26 | Vyome Therapeutics Limited | Besifloxacin for the treatment of resistant acne |
RU2545915C1 (ru) * | 2014-02-14 | 2015-04-10 | Олег Васильевич Рубальский | Способ лечения хронического болевого синдрома |
RU2545798C1 (ru) * | 2014-03-24 | 2015-04-10 | Закрытое акционерное общество "ФИРН М" (ЗАО "ФИРН М") | Фармацевтическая композиция для оказания первой медицинской помощи при ожогах различной этиологии, площади и глубины в форме спрея, геля, аэрозоля |
RU2603490C1 (ru) * | 2015-11-30 | 2016-11-27 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Средство для лечения гнойно-воспалительных процессов мягких тканей и слизистых оболочек |
RU2605343C1 (ru) * | 2015-11-30 | 2016-12-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Средство для лечения гнойно-воспалительных процессов мягких тканей и слизистых оболочек |
-
2017
- 2017-02-22 RU RU2017106061A patent/RU2649785C1/ru active
- 2017-12-14 KR KR1020197023386A patent/KR102096257B1/ko active IP Right Grant
- 2017-12-14 MX MX2019009761A patent/MX2019009761A/es unknown
- 2017-12-14 CN CN201780084018.6A patent/CN110198721B/zh active Active
- 2017-12-14 BR BR112019016560-6A patent/BR112019016560A2/pt unknown
- 2017-12-14 EA EA201991275A patent/EA037319B1/ru unknown
- 2017-12-14 SG SG11201903097UA patent/SG11201903097UA/en unknown
- 2017-12-14 PL PL17836069T patent/PL3585399T3/pl unknown
- 2017-12-14 US US16/480,536 patent/US11045551B2/en active Active
- 2017-12-14 JP JP2019535309A patent/JP6690816B2/ja active Active
- 2017-12-14 WO PCT/RU2017/000905 patent/WO2018156051A1/en unknown
- 2017-12-14 EP EP17836069.9A patent/EP3585399B1/en active Active
- 2017-12-14 MA MA46159A patent/MA46159B1/fr unknown
- 2017-12-14 GE GEAP201715119A patent/GEP20207136B/en unknown
- 2017-12-14 CA CA3054002A patent/CA3054002C/en active Active
- 2017-12-14 AU AU2017400650A patent/AU2017400650B2/en not_active Ceased
- 2017-12-14 UA UAA201907164A patent/UA121949C2/uk unknown
-
2019
- 2019-08-09 CL CL2019002259A patent/CL2019002259A1/es unknown
- 2019-08-13 ZA ZA2019/05343A patent/ZA201905343B/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA46159A1 (fr) | 2021-04-30 |
CN110198721A (zh) | 2019-09-03 |
AU2017400650B2 (en) | 2019-09-26 |
US11045551B2 (en) | 2021-06-29 |
PL3585399T3 (pl) | 2022-05-30 |
RU2649785C1 (ru) | 2018-04-04 |
CN110198721B (zh) | 2022-06-07 |
EP3585399B1 (en) | 2022-02-09 |
EA037319B1 (ru) | 2021-03-11 |
KR102096257B1 (ko) | 2020-04-06 |
MA46159B1 (fr) | 2022-04-29 |
UA121949C2 (uk) | 2020-08-10 |
SG11201903097UA (en) | 2019-09-27 |
ZA201905343B (en) | 2021-08-25 |
KR20190099338A (ko) | 2019-08-26 |
GEP20207136B (en) | 2020-07-27 |
JP6690816B2 (ja) | 2020-04-28 |
EA201991275A1 (ru) | 2019-11-29 |
BR112019016560A2 (pt) | 2020-03-31 |
MX2019009761A (es) | 2019-10-07 |
EP3585399A1 (en) | 2020-01-01 |
CA3054002C (en) | 2021-07-20 |
AU2017400650A1 (en) | 2019-07-18 |
US20190381176A1 (en) | 2019-12-19 |
JP2020506164A (ja) | 2020-02-27 |
WO2018156051A1 (en) | 2018-08-30 |
CA3054002A1 (en) | 2018-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP20040257A (es) | Nuevas piridopirimidinonas sustituidas con bencilamino y derivados como inhibidores de sos1 | |
SV2018005778A (es) | Derivados aromaticos de sulfonamida | |
PE20191474A1 (es) | Compuestos de amino-triazolopiridina y su uso en el tratamiento del cancer | |
BR112021006392A2 (pt) | moduladores da alfa-1 antitripsina | |
UY37098A (es) | Moduladores de ror-gamma | |
CR20170563A (es) | Compuestos de benzoxacepina oxazolidinona y métodos de uso. | |
SV2018005750A (es) | Derivados de compuestos de indol sustituidos como inhibidores de la replicacion virica del dengue | |
BR112015027699A2 (pt) | Uso de robenidina ou um sal terapeuticamente aceitável da mesma, composição farmacêutica antibacteriana e dispositivo médico | |
BR112015021858A2 (pt) | curativo antimicrobiano combinado para cobertura de cateter | |
CO2017003838A2 (es) | Compuestos de aminopurina sustituida, composiciones del mismo, y métodos de tratamiento con los mismos | |
CL2019003398A1 (es) | Inhibidores pirazólicos de magl. | |
BR112017004153A2 (pt) | métodos para tratamento de infecções por protozoários | |
CO2019001236A2 (es) | Compuestos y métodos para la modulación de smn2 | |
BR112015023157A2 (pt) | composições hidrocoloides, bandagem para ferimentos e método de formação de uma composição hidrocoloide | |
BR112017006406A2 (pt) | composições e métodos para o tratamento e profilaxia de infecções de sítio cirúrgico | |
DOP2017000146A (es) | Pirazolpiridinaminas como inhibidores de mknk1 y mknk2 | |
CO7240418A2 (es) | Apósito con una liberación prolongada de agentes activos | |
CL2021001388A1 (es) | Compuestos útiles en la terapia para el vih | |
CO2022000481A2 (es) | Inhibidores de enzimas | |
CL2021000329A1 (es) | Compuestos útiles en terapia del vih | |
CL2021001044A1 (es) | Uso de plasma y fracciones de plasma para mejorar el dolor, la cicatrización de heridas y la recuperación posoperatoria | |
UY37729A (es) | NUEVOS COMPUESTOS QUE INHIBEN LA ACTIVIDAD DE Nav1.7 | |
CL2021000509A1 (es) | Composiciones farmacéuticas semisólidas de base oleosa conteniendo pirfenidona para su aplicación en la reparación tisular | |
ECSP13013075A (es) | Método de tratamiento de la fiebre dengue | |
CL2019002480A1 (es) | Derivados de pirazol como inhibidores de bromodominio. |